drugset / Trial / NCT02258867
Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to assess the efficacy and safety of gevokizumab in treating Behcet's disease uveitis (BDU).
Timeline
- Start
- 2014-11
- Primary completion
- 2015-10
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gevokizumab | Monoclonal antibody | — | Subcutaneous |